Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
about
Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users.Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United StatesTrends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A ReviewPrescription drug misuse among homeless youth.The societal cost of heroin use disorder in the United States.A Community Partnership to Respond to the Heroin and Opioid Abuse Epidemic.Sources of pharmaceutical opioids for non-medical use among young adultsAcetyl Fentanyl, a Novel Fentanyl Analog, Causes 14 Overdose Deaths in Rhode Island, March-May 2013.Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.The multi-site prescription opioid addiction treatment study: 18-month outcomesPrescription drug abuse: from epidemiology to public policyIncreases in heroin overdose deaths - 28 States, 2010 to 2012.Prescription opioid misuse and mental health among young injection drug users.Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent populationLong-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment StudyNegotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings.Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City.Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.Factors associated with willingness to take extended release naltrexone among injection drug users.Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.Hot spots in mortality from drug poisoning in the United States, 2007-2009.Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniorsNonmedical Prescription Opioid Use in Childhood and Early Adolescence Predicts Transitions to Heroin Use in Young Adulthood: A National Study.Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study.Past year non-medical opioid use and abuse and PTSD diagnosis: Interactions with sex and associations with symptom clusters.Overdose Education and Naloxone Rescue Kits for Family Members of Individuals Who Use Opioids: Characteristics, Motivations, and Naloxone Use.Epidemiology of Injection Drug Use: New Trends and Prominent Issues.No End in Sight: The Abuse of Prescription Narcotics.A mixed-methods evaluation of the feasibility, acceptability, and preliminary efficacy of a mobile intervention for methadone maintenance clients.Nonmedical Use of Cough Syrup Among Secondary Vocational School Students: A National Survey in ChinaFactors associated with being asked to initiate someone into injection drug usePrescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Pathways through opiate use and offending: A systematic reviewDrug use in business bathrooms: An exploratory study of manager encounters in New York City.
P2860
Q27312280-7A32AFB3-3873-4C15-9874-44AE883D4344Q28396625-3B7611D8-29D2-47BF-9415-80692ADF19F0Q28533642-48A0D86B-DBAE-40A9-9CA9-FD846785C678Q30235088-36BC07FC-3F40-4F8A-95A5-D6FA62C2CA12Q33644065-6DA14A79-CF0B-4464-BE11-FD9BD1381327Q33739154-7B7C5F9E-D578-443D-8D5E-B72D9020FF28Q33925184-915ED461-54C9-4CEA-9433-239C671A3406Q33956591-F2E253C1-C1C7-4704-A551-BBDE29936F8FQ34474670-420896E3-371A-40B4-B829-D6B61B4C24F8Q34602741-C97697A0-43FB-4FC8-AFF4-E4146DB80383Q34602946-E1DE22FE-E7FA-4389-AFA9-5345BFDEF4E2Q34603363-E3C1BF75-5E30-4630-8E4D-A84633F849E1Q34665115-2C5CE01E-3E49-4862-B936-D21A324BD41EQ34674284-136A3F0D-66B5-4F13-8AE8-A271A104DA49Q35154999-49C647D2-2AB3-4706-B340-2E1296F6497BQ35532106-227E8C73-2314-48D0-AA25-1E902E076CF0Q35581138-959153CA-507C-4B97-A8BF-AFFDF62EF497Q35795201-2CEF44A2-F2F3-4BF1-9DF9-57D588C00799Q35923117-667B2AFB-2EFB-4F8B-AAE9-7507A9152ADAQ35923351-F2B4CC0D-5133-443A-87F5-1D95174D2C6BQ36080932-DF5CED36-96C0-4F79-8070-A4141E8CDB0BQ36093144-D57DBF41-84AC-420F-B164-13F1B98737A0Q36248819-05465068-FC2F-4CDD-83D5-4B864CE63698Q36259160-E439238C-60E4-475B-8158-A727D783F997Q36315633-3A6A3589-530A-49DF-B4BE-5BF80F71569BQ36319037-BB5D55A2-2259-4520-992E-8DEA6639663EQ36421383-D4EC4C99-D4F4-4EA4-B9FA-8FFA5CCB6EFFQ36468218-6DF2DD85-34E8-42CE-B1A6-8F2F69D3833BQ36549928-0E467A49-39B6-4B7F-A8C2-2689D3603A60Q36619410-51C56184-EF16-45B7-9EB7-D3A590E46093Q36730877-91A2B867-FF0A-4CBD-830E-1485CDDD1DC3Q36733605-EE81B7F1-C1D3-4600-988C-A084336BC579Q36744335-16F04413-CAB7-48BC-945E-4264612A69F6Q37035647-F47B6782-7156-4D66-8517-E3AE6D1255D7Q37046294-5362F69D-EFC0-4FE2-A873-1BB5606ED5F7Q37207034-5F11F816-5786-48B2-B18A-3C6044D98CA7Q37308020-6FCFA7A1-E1D2-4C20-B23F-C0C37FBE8015Q37309608-B0C6144E-BAC3-40C6-B49E-4969CAE85DCFQ37585371-F12FC2CB-3A5F-4605-B0D5-84116DA313D3Q37638349-6FD842FC-5755-4A6F-BAEF-8E2DDC563F29
P2860
Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@en
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@nl
type
label
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@en
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@nl
prefLabel
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@en
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@nl
P1476
Heroin use and heroin use risk ...... ates, 2002-2004 and 2008-2010.
@en
P2093
Christopher M Jones
P304
P356
10.1016/J.DRUGALCDEP.2013.01.007
P577
2013-02-12T00:00:00Z